| Literature DB >> 33971090 |
Derek A Leas1, Austin G Sanford2,3, Jianbo Wu1, Monica Cal4,5, Marcel Kaiser4,5, Sergio Wittlin4,5, Ryan M Hemsley3, Elyssa B Darner3, LeeAnna M Lui3, Paul H Davis3, Jonathan L Vennerstrom1.
Abstract
We now describe the physicochemical profiling, in vitro ADME, and antiparasitic activity of eight N,N'-diarylureas to assess their potential as a broad-spectrum antiprotozoal chemotype. Chromatographic LogD7.4 values ranged from 2.5 to 4.5; kinetic aq. solubilities were ≤6.3 μg/mL, and plasma protein binding ranged from 95 to 99%. All of the compounds had low intrinsic clearance values in human, but not mouse, liver microsomes. Although no N,N'-diarylurea had submicromolar potency against Trypanosoma cruzi, two had submicromolar potencies against Toxoplasma gondii and Trypanosoma brucei rhodesiense, and five had submicromolar potencies against Leishmania donovani. Plasmodium falciparum appeared to be the most susceptible to growth inhibition by this compound series. Most of the N,N'-diarylureas had antiprotozoal selectivities ≥10. One N,N'-diarylurea had demonstrable activity in mouse models of malaria and toxoplasmosis.Entities:
Keywords: N,N′-diarylurea; antiprotozoal; chemotype
Mesh:
Substances:
Year: 2021 PMID: 33971090 PMCID: PMC8802619 DOI: 10.1021/acsinfecdis.1c00135
Source DB: PubMed Journal: ACS Infect Dis ISSN: 2373-8227 Impact factor: 5.578